当前位置:首页 - 行情中心 - 津药药业(600488) - 财务分析

津药药业

(600488)

  

流通市值:43.24亿  总市值:43.32亿
流通股本:10.92亿   总股本:10.94亿

津药药业(600488)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2023年年度实现净利润1.63亿元,每股收益0.11元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2023年年度最新股东权益375330.39万元,未分配利润125772.11万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2023年年度最新总资产614248.22万元,负债238917.83万元。

利润表
报告期2023-12-312023-09-302023-06-302023-03-31
营业总收入3,782,826,621.152,837,778,648.872,023,258,856.62990,540,207.94
营业总成本3,590,176,148.182,593,674,378.541,821,004,304.04866,504,739.66
营业利润169,407,081.21212,028,534169,394,062.6993,656,566.52
利润总额168,239,822.16211,175,860.01168,622,358.4993,729,607.32
净利润162,673,103.95193,967,421.24155,321,277.3986,684,786.16
其他综合收益-121,318,766.97,551,204.856,174,818.59728,877.24
综合收益总额41,354,337.05201,518,626.09161,496,095.9887,413,663.4
资产负债表
报告期2023-12-312023-09-302023-06-302023-03-31
流动资产合计2,108,068,217.652,068,573,731.022,301,135,134.642,380,508,890.47
非流动资产合计4,034,413,981.484,197,480,572.524,215,378,671.374,240,767,497.95
资产总计6,142,482,199.136,266,054,303.546,516,513,806.016,621,276,388.42
流动负债合计1,940,298,948.531,876,102,686.551,956,920,927.542,170,001,614.29
非流动负债合计448,879,311.89471,475,158.79653,502,690.57608,279,320.62
负债合计2,389,178,260.422,347,577,845.342,610,423,618.112,778,280,934.91
归属于母公司股东权益合计2,953,554,191.33,122,129,080.053,092,845,105.623,042,515,751.08
股东权益合计3,753,303,938.713,918,476,458.23,906,090,187.93,842,995,453.51
负债和股东权益合计6,142,482,199.136,266,054,303.546,516,513,806.016,621,276,388.42
现金流量表
报告期2023-12-312023-09-302023-06-302023-03-31
经营活动现金流入小计3,635,811,348.022,624,869,908.31,813,560,361.31854,021,932.28
经营活动现金流出小计2,852,803,032.692,159,483,227.931,499,797,869.58671,461,946.18
经营活动产生的现金流量净额783,008,315.33465,386,680.37313,762,491.73182,559,986.1
投资活动现金流入小计1,026,10626,106--
投资活动现金流出小计133,148,159.9989,969,686.1148,947,188.4427,561,016.64
投资活动产生的现金流量净额-132,122,053.99-89,943,580.11-48,947,188.44-27,561,016.64
筹资活动现金流入小计580,500,000580,500,000515,500,00056,000,000
筹资活动现金流出小计1,145,347,835.471,120,786,652.82841,631,346.69183,834,883.84
筹资活动产生的现金流量净额-564,847,835.47-540,286,652.82-326,131,346.69-127,834,883.84
汇率变动对现金及现金等价物的影响8,165,883.79-5,525,647.68-10,840,368.94-1,590,763.62
现金及现金等价物净增加额94,204,309.66-170,369,200.24-72,156,412.3425,573,322
期末现金及现金等价物余额703,007,242.12438,433,732.22536,646,520.12634,376,254.46
TOP↑